{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T12:46:54Z","timestamp":1785588414934,"version":"3.56.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T00:00:00Z","timestamp":1571788800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T00:00:00Z","timestamp":1571788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s00228-019-02766-2","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T16:26:52Z","timestamp":1571848012000},"page":"73-80","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Nortriptyline serum concentration as a predictor for cardiac risk in amitriptyline-treated patients"],"prefix":"10.1007","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4780-612X","authenticated-orcid":false,"given":"Maike","family":"Scherf-Clavel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper","family":"Zebner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif","family":"Hommers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Deckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Menke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Unterecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,23]]},"reference":[{"issue":"5","key":"2766_CR1","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1517\/14656566.1.5.947","volume":"1","author":"I Cavero","year":"2000","unstructured":"Cavero I, Mestre M, Guillon JM, Crumb W (2000) Drugs that prolong QT interval as an unwanted effect: assessing their likelihood of inducing hazardous cardiac dysrhythmias. Expert Opin Pharmacother 1(5):947\u2013973. \nhttps:\/\/doi.org\/10.1517\/14656566.1.5.947","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"2766_CR2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1517\/14656566.3.5.479","volume":"3","author":"PJ Goodnick","year":"2002","unstructured":"Goodnick PJ, Jerry J, Parra F (2002) Psychotropic drugs and the ECG: focus on the QTc interval. Expert Opin Pharmacother 3(5):479\u2013498. \nhttps:\/\/doi.org\/10.1517\/14656566.3.5.479","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"2766_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/jaha.116.003264","volume":"5","author":"B Vandenberk","year":"2016","unstructured":"Vandenberk B, Vandael E, Robyns T, Vandenberghe J, Garweg C, Foulon V, Ector J, Willems R (2016) Which QT correction formulae to use for QT monitoring? J Am Heart Assoc 5(6):1\u201310. \nhttps:\/\/doi.org\/10.1161\/jaha.116.003264","journal-title":"J Am Heart Assoc"},{"issue":"5 Pt 2","key":"2766_CR4","first-page":"174","volume":"44","author":"TL Wenger","year":"1983","unstructured":"Wenger TL, Cohn JB, Bustrack J (1983) Comparison of the effects of bupropion and amitriptyline on cardiac conduction in depressed patients. J Clin Psychiatry 44(5 Pt 2):174\u2013175","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"2766_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1365-2125.1988.tb03397.x","volume":"26","author":"JW Upward","year":"1988","unstructured":"Upward JW, Edwards JG, Goldie A, Waller DG (1988) Comparative effects of fluoxetine and amitriptyline on cardiac function. Br J Clin Pharmacol 26(4):399\u2013402. \nhttps:\/\/doi.org\/10.1111\/j.1365-2125.1988.tb03397.x","journal-title":"Br J Clin Pharmacol"},{"issue":"648","key":"2766_CR6","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1136\/pgmj.55.648.704","volume":"55","author":"CD Burgess","year":"1979","unstructured":"Burgess CD, Montgomery S, Wadsworth J, Turner P (1979) Cardiovascular effects of amitriptyline, mianserin, zimelidine and nomifensine in depressed patients. Postgrad Med J 55(648):704\u2013708. \nhttps:\/\/doi.org\/10.1136\/pgmj.55.648.704","journal-title":"Postgrad Med J"},{"issue":"3","key":"2766_CR7","first-page":"91","volume":"44","author":"K White","year":"1983","unstructured":"White K, O\u2019Leary J, Razani J, Rebal R, Palmer R (1983) Electrocardiographic effects of tranylcypromine vs. amitriptyline. J Clin Psychiatry 44(3):91\u201393","journal-title":"J Clin Psychiatry"},{"issue":"5 Pt 2","key":"2766_CR8","first-page":"8","volume":"43","author":"DS Robinson","year":"1982","unstructured":"Robinson DS, Nies A, Corcella J, Cooper TB, Spencer C, Keefover R (1982) Cardiovascular effects of phenelzine and amitriptyline in depressed outpatients. J Clin Psychiatry 43(5 Pt 2):8\u201315","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"2766_CR9","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/00007691-200108000-00019","volume":"23","author":"B Rodriguez de la Torre","year":"2001","unstructured":"Rodriguez de la Torre B, Dreher J, Malevany I, Bagli M, Kolbinger M, Omran H, Luderitz B, Rao ML (2001) Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients. Ther Drug Monit 23(4):435\u2013440","journal-title":"Ther Drug Monit"},{"issue":"6","key":"2766_CR10","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/BF00637499","volume":"23","author":"OL Pedersen","year":"1982","unstructured":"Pedersen OL, Gram LF, Kristensen CB, Moller M, Thayssen P, Bjerre M, Kragh-SoRensen P, Klitgaard NA, Sindrup E, Hole P, Brinklo M (1982) Overdosage of antidepressants: clinical and pharmacokinetic aspects. Eur J Clin Pharmacol 23(6):513\u2013521. \nhttps:\/\/doi.org\/10.1007\/BF00637499","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"2766_CR11","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/jcp.0000000000000336","volume":"35","author":"S Unterecker","year":"2015","unstructured":"Unterecker S, Pfuhlmann B, Kopf J, Kittel-Schneider S, Reif A, Deckert J (2015) Increase of heart rate and QTc by amitriptyline, but not by venlafaxine, is correlated to serum concentration. J Clin Psychopharmacol 35(4):460\u2013463. \nhttps:\/\/doi.org\/10.1097\/jcp.0000000000000336","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"2766_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1055\/s-0044-102009","volume":"52","author":"G Hefner","year":"2019","unstructured":"Hefner G, Hahn M, Hohner M, Roll SC, Klimke A, Hiemke C (2019) QTc time correlates with amitriptyline and venlafaxine serum levels in elderly psychiatric inpatients. Pharmacopsychiatry 52(1):38\u201343. \nhttps:\/\/doi.org\/10.1055\/s-0044-102009","journal-title":"Pharmacopsychiatry"},{"key":"2766_CR13","doi-asserted-by":"publisher","first-page":"f288","DOI":"10.1136\/bmj.f288","volume":"346","author":"VM Castro","year":"2013","unstructured":"Castro VM, Clements CC, Murphy SN, Gainer VS, Fava M, Weilburg JB, Erb JL, Churchill SE, Kohane IS, Iosifescu DV, Smoller JW, Perlis RH (2013) QT interval and antidepressant use: a cross sectional study of electronic health records. Bmj 346:f288. \nhttps:\/\/doi.org\/10.1136\/bmj.f288","journal-title":"Bmj"},{"issue":"1","key":"2766_CR14","first-page":"11","volume":"60","author":"Y Funai","year":"2014","unstructured":"Funai Y, Funao T, Ikenaga K, Takahashi R, Hase I, Nishikawa K (2014) Use of tricyclic antidepressants as analgesic adjuvants results in nonhazardous prolongation of the QTc interval. Osaka City Med J 60(1):11\u201319","journal-title":"Osaka City Med J"},{"issue":"1","key":"2766_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1600-0447.1987.tb02746.x","volume":"75","author":"V Kumar","year":"1987","unstructured":"Kumar V, Smith RC, Reed K, Leelavathi DE (1987) Plasma levels and effects of nortriptyline in geriatric depressed patients. Acta Psychiatr Scand 75(1):20\u201328. \nhttps:\/\/doi.org\/10.1111\/j.1600-0447.1987.tb02746.x","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"2766_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/00004714-199702000-00004","volume":"17","author":"B Baker","year":"1997","unstructured":"Baker B, Dorian P, Sandor P, Shapiro C, Schell C, Mitchell J, Irvine MJ (1997) Electrocardiographic effects of fluoxetine and doxepin in patients with major depressive disorder. J Clin Psychopharmacol 17(1):15\u201321","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"2766_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/clpt.1987.102","volume":"42","author":"EG Giardina","year":"1987","unstructured":"Giardina EG, Cooper TB, Suckow R, Saroff AL (1987) Cardiovascular effects of doxepin in cardiac patients with ventricular arrhythmias. Clin Pharmacol Ther 42(1):20\u201327","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"2766_CR18","first-page":"460","volume":"45","author":"S Ahles","year":"1984","unstructured":"Ahles S, Gwirtsman H, Halaris A, Shah P, Schwarcz G, Hill MA (1984) Comparative cardiac effects of maprotiline and doxepin in elderly depressed patients. J Clin Psychiatry 45(11):460\u2013465","journal-title":"J Clin Psychiatry"},{"key":"2766_CR19","first-page":"1972","volume":"28-29","author":"W Haverkamp","year":"2002","unstructured":"Haverkamp W, Haverkamp F, Breithardt G (2002) Medikamentenbedingte QT-Verl\u00e4ngerung und Torsade de pointes: Ein multidisziplin\u00e4res Problem. Dtsch Arztebl Int 28-29:1972\u20131999","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"2766_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0022-3956(89)90019-8","volume":"23","author":"RE McCue","year":"1989","unstructured":"McCue RE, Georgotas A, Nagachandran N, Abdul Basir M, Go EA, Suckow RF, Cooper TB (1989) Plasma levels of nortriptyline and 10-hydroxynortriptyline and treatment-related electrocardiographic changes in the elderly depressed. J Psychiatr Res 23(1):73\u201379. \nhttps:\/\/doi.org\/10.1016\/0022-3956(89)90019-8","journal-title":"J Psychiatr Res"},{"issue":"1","key":"2766_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000117732","volume":"6","author":"JL Nielsen","year":"1980","unstructured":"Nielsen JL (1980) ECG changes during treatment with nortriptyline in a once-a-day dosage. Neuropsychobiology 6(1):48\u201351. \nhttps:\/\/doi.org\/10.1159\/000117732","journal-title":"Neuropsychobiology"},{"issue":"6","key":"2766_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/00004714-198812000-00004","volume":"8","author":"LS Schneider","year":"1988","unstructured":"Schneider LS, Cooper TB, Severson JA, Zemplenyi T, Sloane RB (1988) Electrocardiographic changes with nortriptyline and 10-hydroxynortriptyline in elderly depressed outpatients. J Clin Psychopharmacol 8(6):402\u2013408. \nhttps:\/\/doi.org\/10.1097\/00004714-198812000-00004","journal-title":"J Clin Psychopharmacol"},{"issue":"1\u201302","key":"2766_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1055\/s-0037-1600991","volume":"51","author":"C Hiemke","year":"2018","unstructured":"Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Grunder G, Haen E, Havemann-Reinecke U, Hefner G, Helmer R, Janssen G, Jaquenoud E, Laux G, Messer T, Mossner R, Muller MJ, Paulzen M, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Schoretsanitis G, Schwarz M, Gracia MS, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Unterecker S, Waschgler R, Zernig G, Zurek G, Baumann P (2018) Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry 51(1\u201302):9\u201362. \nhttps:\/\/doi.org\/10.1055\/s-0037-1600991","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"2766_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/YIC.0000000000000250","volume":"34","author":"M Scherf-Clavel","year":"2019","unstructured":"Scherf-Clavel M, Samanski L, Hommers LG, Deckert J, Menke A, Unterecker S (2019) Analysis of smoking behavior on the pharmacokinetics of antidepressants and antipsychotics: evidence for the role of alternative pathways apart from CYP1A2. Int Clin Psychopharmacol 34(2):93\u2013100. \nhttps:\/\/doi.org\/10.1097\/YIC.0000000000000250","journal-title":"Int Clin Psychopharmacol"},{"issue":"2","key":"2766_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1542-474X.1997.tb00325.x","volume":"2","author":"HC Bazett","year":"1997","unstructured":"Bazett HC (1997) An analysis of the time-relations of electrocardiograms. Ann Noninvasive Electrocardiol 2(2):177\u2013194. \nhttps:\/\/doi.org\/10.1111\/j.1542-474X.1997.tb00325.x","journal-title":"Ann Noninvasive Electrocardiol"},{"issue":"4","key":"2766_CR26","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1046\/j.1542-474X.2003.08413.x","volume":"8","author":"LS Fridericia","year":"2003","unstructured":"Fridericia LS (2003) The duration of systole in an electrocardiogram in normal humans and in patients with heart disease. Ann Noninvasive Electrocardiol 8(4):343\u2013351. \nhttps:\/\/doi.org\/10.1046\/j.1542-474X.2003.08413.x","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"2766_CR27","unstructured":"Hiemke C, Haen E, Eckermann G, Dobmeier M, Singer M, Silva M, Wenzel-Seifert K, Nagel-Hiemke M PSIAC. Springer-Verlag GmbH, Heidelberg. \nhttps:\/\/www.psiac.de\/\n\n. Accessed 18 March 2019"},{"issue":"2","key":"2766_CR28","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/00004583-199303000-00006","volume":"32","author":"TE Wilens","year":"1993","unstructured":"Wilens TE, Biederman J, Spencer T, Geist DE (1993) A retrospective study of serum levels and electrocardiographic effects of nortriptyline in children and adolescents. J Am Acad Child Adolesc Psychiatry 32(2):270\u2013277. \nhttps:\/\/doi.org\/10.1097\/00004583-199303000-00006","journal-title":"J Am Acad Child Adolesc Psychiatry"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02766-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-019-02766-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02766-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T23:13:07Z","timestamp":1603321987000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-019-02766-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,23]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["2766"],"URL":"https:\/\/doi.org\/10.1007\/s00228-019-02766-2","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,23]]},"assertion":[{"value":"16 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"J. Deckert is the co-recipient of a grant of the Bavarian State Government to BioVariance and an investigator in a European grant to P1Vital. A. Menke has given talks for the health insurance company AOK, Servier, Recordati, and Medice. M. Scherf-Clavel, J. Zebner, L. Hommers, and S. Unterecker have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in the analysis involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study (retrospective analysis with anonymous naturalistic data), formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}